A Phase III, Randomized, Double-Blind Placebo-Controlled, Multicenter Study To Evaluate the Efficacy and Safety of Baloxavir Marboxil in Combination With Standard-of-Care Neuraminidase Inhibitor in Hospitalized Participants With Severe Influenza
收藏DataCite Commons2026-01-05 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008869/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study will evaluate the efficacy, safety, and pharmacokinetics of baloxavir marboxil in
combination with a standard-of-care (SOC) neuraminidase inhibitor (NAI) (i.e., oseltamivir,
zanamivir, or peramivir) compared with a matching placebo in combination with a SOC NAI in
hospitalized patients with influenza.
提供机构：
Vivli
创建时间：
2023-03-28
